Calculating Opioid Dose Conversions
Fast Fact Number: 36
By: Robert M Arnold MD, David E Weissman MD
Categories: Age Friendly Care: The 4 Ms of Geriatric Care, Medications, Opioids and Opioid-Related Side Effects, Pharmacology
Published On: October 1, 2024
Introduction A variety of published conversion tables and online calculators exist to provide clinicians a rough guide for making calculations when switching between different opioid routes or preparations. Listed below are methods for common conversions using standard published conversion ratios. The examples assume a change in drug or route at a time of stable pain control using equianalgesic doses. See Fast Fact #2 about conversions involving transdermal fentanyl; Fast Fact #75 and Fast Fact #86 about methadone
Caution: Published values in equianalgesic tables should be considered a rough clinical guide when making dose conversions as substantial inter-individual variation exists. In fact, the very premise of equianalgesic tables may be flawed in that they assume an equal bidirectional ratio when converting routes, when the ratio from oral (PO) to intravenous (IV) morphine for example is different from IV to oral. Hence there is emerging consensus among experts that online calculators that provide a specific ratio to go from opioid X to opioid Y are likely safer and more accurate. Regardless of whether you utilize a table or online calculator, the final prescribed dose needs to account for a patients’ age, renal, and hepatic function; their current pain level and opioid side effects such as sedation; prognosis; and care goals.
Opioid Equianalgesic Conversion Ratios for use with the following examples:
Morphine 10 mg parenteral = Morphine 25 mg oral = Hydromorphone 2 mg parenteral = Hydromorphone 5 mg oral = Hydrocodone 25 mg oral = Oxycodone 20 mg oral (see References 4 and 5).
A. Change route, keeping drug the same (e.g. oral to IV morphine)
Example: Change 90 mg q12 extended-release morphine to morphine by IV continuous infusion
- Calculate the 24-hour current dose: 90mg q 12 = 180 mg morphine/24 hours
- Use the oral to parenteral equianalgesic ratio: 25 mg PO morphine = 10 mg IV Morphine or a 2.5:1 ratio.
- Calculate new dose using ratios: 180/2.5 = 72 mg IV morphine/24 hours or 3 mg/hour infusion
- Some experts recommend starting the new opioid at roughly 75% of the calculated dose to account for inter-individual variation in first pass clearance and safety.
- 3 mg/hr x 0.75 = 2.25 mg/hr or 2 mg/hr infusion would be the closely whole number interval.
B. Change drug, keep the same route (e.g. po morphine to po hydromorphone)
There is individual variability in the ratio between different opioids. Equianalgesic ratios and online calculators only provide a guide or approximations. Depending on age and prior side effects, most experts recommend starting a new opioid at 50-75% of the calculated equianalgesic dose, in the setting of well-controlled pain.
Change 90 mg q 12 extended-release morphine to oral hydromorphone.
- Calculate the 24-hour current dose: 90 Q12 x 2 = 180 mg PO morphine/24 hrs
- Use the equianalgesic ratio: 25 mg PO morphine = 5 mg PO hydromorphone, which is a 5:1 ratio
- Calculate new dose using ratios: 180/5 = 36 mg oral hydromorphone/24 hours
- For this example, reduce dose 50% for cross-tolerance: 36 x 0.5 = 18 mg/24 hours = 3 mg q4h
C. Changing drug and route (e.g. oral morphine to IV hydromorphone)
Change from 90 mg q12 extended-release morphine to IV hydromorphone as a continuous infusion.
- Calculate the 24-hour current dose: 90 Q12 x 2 = 180 mg PO morphine/24 hrs
- Use the equianalgesic ratio of PO to IV morphine: 25 mg po morphine = 10 mg IV Morphine (or a 2.5 to 1 ratio)
- Calculate new dose using ratios: 180/2.5 = 72 mg IV morphine/24 hours
- Use the equianalgesic ratio of 10 mg IV morphine to 2 mg IV hydromorphone (a 5 to 1 ratio)
- Calculate new dose using ratios: 72/5 = 14 mg IV hydromorphone/24 hours
- Reduce dose 50% for cross-tolerance: 14 x 0.5 = 7 mg/24 hours = 0.3 mg IV continuous infusion
References:
- Gammaitoni AR, Fine P, Alvarez N, McPherson ML. Clinical application of opioid equianalgesic data. Clin J Pain. 2003; 19:286-297.
- Pereira J et al. Equianalgesic dose rations for opioids: a critical review and proposals for long-term dosing. J Pain Sym Manage. 2001; 22:672-687.
- Anderson R et al. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Sym Manage. 2001; 21:397-406.
- Reddy A, Vidal M, Stephen S, et al. The conversion ratio from intravenous hydromorphone to oral opioids in cancer patients. J Pain Symptom Manage 2017; 54(3):280-288.
- McPherson ML. Demystifying opioid conversion calculations: a guide for effective dosing. 2nd ed. Bethesda:ASHP; ©2018.
Version History: This Fast Fact was originally edited by David E Weissman MD. 2nd Edition published July 2005; 3rd Edition May 2015; 4th Edition in September 2024.
Fast Facts and Concepts are edited by Sean Marks MD (Medical College of Wisconsin) and associate editor Drew A Rosielle MD (University of Minnesota Medical School) with the generous support of a volunteer peer-review editorial board, and are made available online by the Palliative Care Network of Wisconsin (PCNOW). The authors of each individual Fast Fact and the Fast Fact and Concepts editors are solely responsible for that Fast Fact’s content. The full set of Fast Facts are available at Palliative Care Network of Wisconsin with contact information, and how to reference Fast Facts.
Copyright: All Fast Facts and Concepts are published under a Creative Commons Attribution-NonCommercial 4.0 International Copyright (http://creativecommons.org/licenses/by-nc/4.0/). Fast Facts can only be copied and distributed for non-commercial, educational purposes. If you adapt or distribute a Fast Fact, let us know!
Disclaimer: Fast Facts and Concepts provide educational information for health care professionals. This information is not medical advice. Fast Facts are not continually updated, and new safety information may emerge after a Fast Fact is published. Health care providers should always exercise their own independent clinical judgment and consult other relevant and up-to-date experts and resources. Some Fast Facts cite the use of a product in a dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.